Wrong. Met (smashed out of the park) the secondary clinical endpoint of the trial, which was the clinical endpoint of greatest significance. Do you think the FDA will be advanced enough to ponder what the primary and secondary endpoints are, and therefore determine what these scientifically rigorous results signify, or will they be goats bleating primary endpoint over and over while furiously ignoring reality. No no, of course if the endpoint met was not the primary endpoint all trial data is invalid, silly me inviting logic into rebuking a troll. Keep singing your song all you like, we can read.
Wrong. Met (smashed out of the park) the secondary clinical...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.070(6.45%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $20.88M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 59978 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 34019 | 3 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.070 ( 5.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 3733217 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |